Parmax Pharma Limited (BSE:540359) announced a private placement of 13,59,500 common shares on January 16, 2021. The transaction will include participation from Promoter and Non-promoter entities and do other ancillary activities. The company will issue securities through preferential allotment method. The transaction has been approved by the board of directors of the company.